ESTRO 2021 Abstract Book

S716

ESTRO 2021

Conclusion Pathological complete response and a priori eligibility for CROSS protocol are critical prognostic factors influencing both OS and RFS in patients undergoing NA-CRT and Surgery for oesophageal carcinomas.

PD-0880 Could 18-FDG PET/CT radiomics features predict outcomes in locally advanced esophageal cancer? L. Lefebvre 1 , J. Henriques 2,3 , A. Falcoz 2,3 , A. Meurisse 4,3 , G. Crehange 5 , L. Boldrini 6 , N. Dinapoli 6 , D. Vernerey 2,3 , R. Gatta 7 , B. De Bari 8,1 1 University Hospital of Besançon, Radiation Oncology, Besançon, France; 2 University Hospital of Besançon, Methodology and Quality of Life in Oncology Unit, Besançon, France; 3 Bourgogne Franche-Comté University, INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon- Tumeur/Ingénierie Cellulaire et Génique, Besançon, France; 4 Univversity Hospital of Besançon, Methodology